IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
206. 26
-4.23
-2.0096%
$
34.42B Market Cap
38.04 P/E Ratio
- Div Yield
1.26M Volume
10.19 Eps
$ 210.49
Previous Close
Add Transaction
Day Range
205.8 211.64
Year Range
154.5 247.05
Want to track IQV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

IQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 2 months ago
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
IQVIA Q1 Earnings Call Highlights

IQVIA Q1 Earnings Call Highlights

IQVIA NYSE: IQV reported record first-quarter revenue and adjusted diluted earnings per share for 2026, with management citing accelerating organic growth across its Commercial Solutions and R&D Solutions businesses, increased demand tied to artificial intelligence offerings and continued strength in forward-looking clinical development metrics.

Marketbeat | 2 months ago
Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings

Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 2 months ago
IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
IQV Q1 Earnings Beat on Commercial Solutions Strength

IQV Q1 Earnings Beat on Commercial Solutions Strength

IQVIA tops on Q1 EPS and revenues on strong Commercial Solutions growth, lifts its 2026 EPS outlook and keeps the revenue & EBITDA guidance steady.

Zacks | 2 months ago
IQVIA Holdings (IQV) Q1 Earnings and Revenues Beat Estimates

IQVIA Holdings (IQV) Q1 Earnings and Revenues Beat Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.83 per share. This compares to earnings of $2.7 per share a year ago.

Zacks | 2 months ago
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Here's Why You Should Retain IQV Stock in Your Portfolio Now

Here's Why You Should Retain IQV Stock in Your Portfolio Now

IQVIA's AI push with NVIDIA, strategic deals and buybacks drive growth, but weakening liquidity raises concerns over near-term financial flexibility.

Zacks | 3 months ago
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
IQVIA Holdings Inc. $IQV Stock Holdings Lifted by Broyhill Asset Management LLC

IQVIA Holdings Inc. $IQV Stock Holdings Lifted by Broyhill Asset Management LLC

Broyhill Asset Management LLC increased its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 15.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 27,010 shares of the medical research company's stock after buying an additional 3,560 shares during the

Defenseworld | 4 months ago
Loading...
Load More